Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 1,762,600 | $214,914 | — | — |
| Q3 2025 | 8,300 | $832 | — | — |
| Q2 2024 | 321,400 | $29,797 | — | — |
| Q1 2024 | 98,800 | $9,375 | — | — |
| Q4 2023 | 267,600 | $23,894 | — | — |
| Q1 2023 | 733,839 | $55,926 | — | — |
| Q4 2022 | 790,670 | $65,626 | — | — |
| Q3 2022 | 663,400 | $52,621 | — | — |
| Q1 2022 | 371,500 | $33,390 | — | — |
| Q4 2021 | 125,358 | $14,035 | — | — |
| Q3 2021 | 84,396 | $10,609 | — | — |
| Q2 2021 | 173,200 | $23,451 | — | — |
| Q1 2021 | 398,296 | $54,029 | — | — |
| Q4 2020 | 349,996 | $49,272 | — | — |
| Q3 2020 | 63,800 | $7,109 | — | — |
| Q1 2020 | 40,770 | $3,157 | — | — |
| Q4 2019 | 967,405 | $92,010 | — | — |
| Q3 2019 | 689,049 | $52,540 | — | — |
| Q2 2019 | 292,908 | $25,691 | — | — |
| Q1 2019 | 7,740 | $701 | — | — |
| Q4 2018 | 31,581 | $2,266 | — | — |
| Q3 2018 | 7,347 | $704 | — | — |